Browse Studies — Arctuva

Phase 1

A Multi-cohort Study of Retifanlimab With or Without Gemcitabine and Docetaxel in Patients With Advanced Sarcoma

This study is being done to find out whether the study drug Retifanlimab, a monoclonal antibody against the PD-1 protein, combined with gemcitabine and docetax…

Soft Tissue SarcomaSarcoma,Soft TissueSarcoma+1 more

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT04577014

Phase 1

Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM): A Multi-cohort Platform Trial of Adaptive Radiotherapy Approaches in Multiple Cancer Types

To characterize feasibility, safety, and/or preliminary efficacy of personalized strategies to adapt standard radiotherapy treatments to individual patient res…

Small Cell Lung Cancer Extensive StageBrain MetastasesSolid Tumor, Adult+3 more

Estimated

~$10 – $6,250

University of Texas Southwestern Medical CenterNCT07139990

Phase 3

A Multicenter, Randomized, Phase 3 Study to Assess the Efficacy and Safety of INtratumorally Administered INT230-6 (SHAO, VINblastine, CIsplatin) Compared With US Standard of Care in Adults With Locally Recurrent, InoperaBLE, or Metastatic Soft Tissue Sarcomas (INVINCIBLE-3)

To compare Overall Survival (OS) for INT230-6 vs United States (US) Standard of Care (SOC) in participants with unresectable or metastatic liposarcoma, undiffe…

Sarcoma,Soft Tissue

Estimated

~$10 – $8,750

Intensity Therapeutics, Inc.NCT06263231

Phase 2

Bacterial Decolonization Plus Intraoperative Indocyanine Green Angiography for Soft Tissue Sarcomas of the Lower Extremity Receiving Preoperative Radiotherapy (CONCERTO)

This trial will investigate the combination of two low-cost, non-toxic strategies to assess whether they can reduce the risk of acute major wound complications…

Sarcoma,Soft Tissue

Estimated

~$10 – $7,500

Adam OlsonNCT06712433